RSV is a common flu-like illness and most often affects infants and older adults.
Six more notes:
1. Although RSV typically peaks in the fall, cases have been on the rise since March, according to the CDC, with July seeing a sharp increase.
2. RSV cases remained low in the fall and early winter of 2020, likely due to COVID-19 pandemic safety measures such as masking and social distancing.
3. Texas Children’s Hospital in Houston is now experiencing a simultaneous increase of both COVID-19 and RSV hospitalizations, Heather Haq, MD, a pediatrician at the hospital, said in a series of tweets cited by the Times.
“We are on the front end of a huge COVID-19 surge,” Dr. Haq said. “But the difference this time compared to previous surges is we are simultaneously dealing with an unheard of summertime RSV surge — creating a ‘surge upon surge situation,’ … We are now having winter-level patient volumes of acutely ill infants/toddlers with RSV, and I worry that we will run out of beds and staff to handle the surge upon surge.”
4. Some patients hospitalized at Texas Children’s Hospital are co-infected with COVID-19 and RSV or other viruses, Dr. Haq wrote.
5. To deal with the increased patient volume, “my pediatric colleagues and I are being called to work mandatory overtime shifts in the coming months,” Dr. Haq said.
6. Florida, Louisiana and Oklahoma are among other states seeing a rise in pediatric RSV infections.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
